Ovidrel Injection, Solution
Product Images NDC 44087-1150

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Ovidrel (NDC 44087-1150). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Emd Serono, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ovidrel 01)

An instructional line drawing showing a person holding a syringe with one hand and injecting into the outer thigh with the other hand. This illustrates the subcutaneous injection technique, relevant for products like Ovidrel injection solution.*

FDA Label Image

Figure 2 (Ovidrel 02)

An instructional illustration showing three steps: administering a subcutaneous injection, closing or securing an injection device, and placing a container labeled 'BIOHAZARD' for disposal. The image visually emphasizes safe injection and proper disposal practices.*

FDA Label Image

Principal Display Panel (250 µg/0.5 mL Syringe Carton)

Ovidrel 250 mcg/0.5 mL injection solution in a prefilled syringe. The label indicates choriogonadotropin alfa for subcutaneous use, prescription only, and is labeled by EMD Serono, Inc. The product NDC 44087-1150 is shown on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.